LEVOFLOXACIN by Teva is 12. Approved for plague, including pneumonic, septicemic plague and 27 more indications. First approved in 2011.
Drug data last refreshed 22h ago
12.1 Mechanism of Action Levofloxacin is a member of the fluoroquinolone class of antibacterial agents [see ] . 12.3 Pharmacokinetics The mean ± SD pharmacokinetic parameters of levofloxacin determined under single and steady-state conditions following administration of the oral tablets, are…
Worked on LEVOFLOXACIN at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
A Study of Levofloxacin Ocular Implant in Patients Undergoing Routine Bilateral Cataract Surgery
Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB
Levofloxacin Ocular Implant for Ocular Surgery
The Clinical Safety of Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%
The Pharmacokinetics of Topical Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%